Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Today, relugolix has been approved for use by the NHS for people living with endometriosis. While it's been praised for its fast action and simple use, campaigners have warned it's by no means a ...

Hoorah for some positive women's health news! A new endometriosis pill has been made available on the NHS in England, in what ...

We believe quality journalism should be available to everyone, paid for by those who can afford it. A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people ...

A transformational new pill for treating endometriosis has been approved for use on the NHS across England. The new tablet, ...

The new drug, called relugolix-estradiol-norethisterone, is a combination pill that blocks specific hormones that contribute to endometriosis, while also providing necessary hormone replacement ...

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

Endometriosis affects approximately 1.5 million women in the UK, leading to chronic pain and fatigue as tissue similar to the ...

A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS. The combination drug could help around 1,000 women every year in England who suffer from the ...

The new pill is the first long-term daily pill licensed to treat the condition, and works by blocking specific hormones that ...

Relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo) is the first long-term daily ...

Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, ...